Patent Assignment
Reel/Frame 029701/0142
Merger
Recorded: 2013-01-28
Pages: 4
Assignor
RAPTOR DISCOVERIES INC.
Executed: 2012-12-28
Assignee
RAPTOR PHARMACEUTICALS INC.
9 COMMERCIAL BLVD., SUITE 200, NOVATO, CALIFORNIA, 94949
Covered Property
(1)
Method for Treating Liver Disorders with Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor Conjugates
Application:
13/016,135 →
Publication:
US 2011/0189084
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2012
From: ZANKEL, TODD C.
To: RAPTOR PHARMACEUTICALS INC.
Reel/Frame 028187/0104 →
Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 028187 Frame 0104. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Raptor Pharmaceutical Inc..
Jul 27, 2012
From: ZANKEL, TODD C.
To: RAPTOR PHARMACEUTICAL INC.
Reel/Frame 028653/0797 →
Change of Name
Jul 30, 2012
From: RAPTOR PHARMACEUTICAL INC.
To: RAPTOR DISCOVERIES INC.
Reel/Frame 028669/0320 →
Security Agreement
Dec 21, 2012
From: RAPTOR PHARMACEUTICAL CORP.; RAPTOR THERAPEUTICS INC.; RAPTOR DISCOVERIES INC.
To: HEALTHCARE ROYALTY PARTNERS II, L.P., AS LENDER
Reel/Frame 029531/0142 →
Release of Security Interest
Oct 25, 2016
From: HEALTHCARE ROYALTY GP II, LLC
To: RAPTOR PHARMACEUTICAL CORP.; RAPTOR DISCOVERIES INC.; RAPTOR PHARMACEUTICALS INC. (AS SUCCESSOR IN INTEREST TO RAPTOR THERAPEUTICS INC.)
Reel/Frame 040121/0801 →
Security Agreement
Oct 26, 2016
From: RAPTOR PHARMACEUTICALS INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040479/0578 →
Change of Name
Dec 20, 2016
From: RAPTOR PHARMACEUTICALS INC.
To: HORIZON ORPHAN LLC
Reel/Frame 041034/0782 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA RAPTOR PHARMACEUTICALS INC.)
Reel/Frame 065178/0955 →